ONE STEP AHEAD IN
Molecular Design

About

Nostrum Biodiscovery is a computational drug discovery technology developer, spun out of the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB Barcelona), two of Spain’s most internationally recognized research centers.

Physics-based simulation meets AI. Our proprietary platforms are built for the targets and modalities others can’t reach: degraders, molecular glues, RNA and nucleic acid therapeutics. PELE® brings physics-based precision to protein-ligand dynamics. XNAHub®, TPD-Suite®, GluePELE and PELETAC extend it to nucleic acids, degraders and glues, while ChaRNABERT adds AI for RNA. Together they form one workflow from target to optimized hit.

Headquartered in Barcelona with an office in Boston, we work with clients in more than 13 countries across Europe, the US and Asia, including five of the top ten global pharmaceutical companies.